Briefing: A setback for Roche’s breast cancer drug
Strategic angle: Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news
Briefing: Fresh turmoil at the FDA with Prasad’s exit
Strategic angle: Prasad out again, generic Ozempic on its way, and more health news from Morning Rounds
Briefing: Talkspace to be acquired for $835 million by mental health services giant
Strategic angle: Universal Health Services announces acquisition of virtual mental health company Talkspace.
Briefing: Health tech company says it will dive into Medicare’s new chronic care experiment
Strategic angle: How a remote patient monitoring company is reworking its tech to enroll in a Medicare program seeking to align payment with health care outcomes.
Evaluating the Risks of AI Chatbots for Medical Advice
The launch of ChatGPT Health by OpenAI prompts a critical examination of the risks associated with AI-driven health consultations.
Strategic view: Health advice from chatbots: what to know before using them
Strategic implications in focus: Following OpenAI's recent ChatGPT Health launch, here are key points to consider before relying on AI chatbots for medical guidance.
Limited Impact of CMS's New Risk-Adjustment Model on Medicare Advantage Benefits
A study in Health Affairs indicates that the new risk-adjustment model from CMS has not substantially altered Medicare Advantage benefits for the 2024-25 period.
Strategic view: Health Care Workforce, Medicare, And More
Strategic implications in focus: An overview of critical issues in health care as discussed in Health Affairs.
Strategic view: Practice Pattern Changes After Adoption Of Diagnostic AI Tool Used In Conjunction With Cardiac Imaging
Strategic implications in focus: Health Affairs, Volume 45, Issue 3, Page 238-245, March 2026.
Disenrollment Rates for Medicare Advantage Beneficiaries Raise Concerns
A recent study indicates that disenrollment rates for Medicare Advantage beneficiaries have tripled between 2017 and 2022, prompting questions about plan stability.
SSDI Beneficiaries Face Increased Mortality Rates During Medicare Waiting Period
A study spanning 2000 to 2021 reveals concerning mortality trends among SSDI beneficiaries awaiting Medicare, highlighting systemic healthcare risks.
Staffing Mandates in Nursing Homes: Analyzing Financial and Operational Outcomes
An examination of nursing home staffing mandates from 2010 to 2023 shows increased staffing levels with negligible financial impact and no notable rise in closures.
Analyzing Labor Unions' Role in Nurse Staffing Ratios and Care Quality
A recent study highlights the complex dynamics between labor unions and nurse staffing ratios in US nursing homes, with implications for care quality.
Servier's $2.5 Billion Acquisition of Day One: Strategic Implications
Servier's acquisition of Day One Biopharmaceuticals for $2.5 billion could reshape its position in the pediatric oncology market, but risks remain.
Strategic view: FDA-UniQure Tussle and Pfizer's Obesity Drug Approval in China
Strategic implications in focus: China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded.
Strategic view: Americans trust Fauci more than RFK Jr.
Strategic implications in focus: The DOJ's fight against gender-affirming care, the impact of Trump's 'Don't take Tylenol,' and more health news.
WHO Reports 13 Verified Attacks on Iranian Health Facilities
The World Health Organization's confirmation of 13 attacks on healthcare sites in Iran raises critical concerns regarding the implications for healthcare safety in conflict zones.
Strategic view: How Do Health Expenditures Vary Across the Population?
Strategic implications in focus: This collection of charts explores the variation in health spending across the population through an analysis of 2023 Medical Expenditure Panel Survey (MEPS) data.